CIRM Funded Clinical Trials

AB-205-301 Phase 3 Trial and Related Activities to Support Clinical Development of AB-205

Disease Area:
B cell cancers
CIRM Grant:
CLIN2-14302 (Active)
Award Value:
Trial Sponsor:
Angiocrine Bioscience, Inc.
Trial Stage:
Phase 3
Trial Status:
Targeted Enrollment:
130 ID:

CIRM Clinical Trial Resources

Patient Stories of Hope

CIRM Alpha Stem Cell Clinics

Patient Toolbox

Video on Stem Cell Trials

Other Resources

ISSCR Patient Website